Hayat Pharmaceutical Industries Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Maher Mohammed Al Kurdi
Chief executive officer
د.أ434.3k
Total compensation
| CEO salary percentage | 63.6% |
| CEO tenure | 22.8yrs |
| CEO ownership | 7.8% |
| Management average tenure | 7.5yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | د.أ3m |
| Mar 31 2024 | n/a | n/a | د.أ2m |
| Dec 31 2023 | د.أ434k | د.أ276k | د.أ2m |
| Sep 30 2023 | n/a | n/a | د.أ2m |
| Jun 30 2023 | n/a | n/a | د.أ2m |
| Mar 31 2023 | n/a | n/a | د.أ3m |
| Dec 31 2022 | د.أ434k | د.أ217k | د.أ4m |
| Sep 30 2022 | n/a | n/a | د.أ3m |
| Jun 30 2022 | n/a | n/a | د.أ3m |
| Mar 31 2022 | n/a | n/a | د.أ2m |
| Dec 31 2021 | د.أ427k | د.أ207k | د.أ4m |
Compensation vs Market: Maher Mohammed's total compensation ($USD612.26K) is above average for companies of similar size in the JO market ($USD81.16K).
Compensation vs Earnings: Maher Mohammed's compensation has been consistent with company performance over the past year.
CEO
Maher Mohammed Al Kurdi (66 yo)
22.8yrs
Tenure
د.أ434,338
Compensation
Dr. Maher Mohammed Ali Al Kurdi is Founder and Non-Independent Executive Vice-Chairman of Hayat Pharmaceutical Industries Co. PLC and has been its Managing Director since February 17, 2002. Dr. Al Kurdi Jo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 22.8yrs | د.أ434.34k | 7.82% JOD 1.9m | |
| Deputy Managing Director of Institutional Development | 3.4yrs | د.أ180.03k | no data | |
| Chief Financial Officer | 7.5yrs | no data | no data |
7.5yrs
Average Tenure
Experienced Management: HPIC's management team is seasoned and experienced (7.5 years average tenure).